Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
JACC. Case Reports|February 18, 2025
tMCS Causing Myocardial Extramedullary Hematopoiesis Secondary to Massive HemolysisRaphael Rothenberger, Yara Banz, Jolie Bruno, et al.Leukemia Research|December 16, 2016
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 yearsAlexander D Heini, Martin D Berger, Katja Seipel, et al.Plos One|August 31, 2013
C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damageClaudia Duehrkop, Yara Banz, Rolf Spirig, et al.Blood|January 10, 2016
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomasMélanie Juilland, Montserrat Gonzalez, Tabea Erdmann, et al.Hematological Oncology|July 15, 2023
Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myelomaCamille Perroud, Dario Thurian, Martin Andres, et al.Journal of Vascular Surgery|February 4, 2018
Effects of C1 inhibitor on endothelial cell activation in a rat hind limb ischemia-reperfusion injury modelShengye Zhang, Jane Shaw-Boden, Yara Banz, et al.BMC Medical Genomics|September 22, 2022
Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasiasEkaterina Rebmann Chigrinova, Naomi A Porret, Martin Andres, et al.Transplantation|May 26, 2018
Local Injections of Tacrolimus-loaded Hydrogel Reduce Systemic Immunosuppression-related Toxicity in Vascularized Composite AllotransplantationDzhuliya V Dzhonova, Radu Olariu, Jonathan Leckenby, et al.JACC. Case Reports|July 18, 2025
Multimodal Imaging Evaluation of Myocardial Involvement in Rare Oculoleptomeningeal Hereditary Transthyretin AmyloidosisMoritz J Hundertmark, Martin Zinkernagel, Tatiana Brémova-Ertl, et al.Cardiovascular Research|September 11, 2007
Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1Yara Banz, Otto M Hess, Simon C Robson, et al.Pageof 12